170 related articles for article (PubMed ID: 34330171)
1. Luminescence Energy Transfer-Based Screening and Target Engagement Approaches for Chemical Biology and Drug Discovery.
Cho EJ; Dalby KN
SLAS Discov; 2021 Sep; 26(8):984-994. PubMed ID: 34330171
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Screening of Transient Receptor Potential Channel 1 Ligands in the Light of the Bioluminescence Resonance Energy Transfer Technique.
Chappe Y; Michel P; Joushomme A; Barbeau S; Pierredon S; Baron L; Garenne A; Poulletier De Gannes F; Hurtier A; Mayer S; Lagroye I; Quignard JF; Ducret T; Compan V; Franchet C; Percherancier Y
Mol Pharmacol; 2021 Sep; 100(3):237-257. PubMed ID: 34127538
[TBL] [Abstract][Full Text] [Related]
3. Use of BRET to Study Protein-Protein Interactions In Vitro and In Vivo.
Dimri S; Basu S; De A
Methods Mol Biol; 2016; 1443():57-78. PubMed ID: 27246334
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement.
Killoran MP; Levin S; Boursier ME; Zimmerman K; Hurst R; Hall MP; Machleidt T; Kirkland TA; Friedman Ohana R
Molecules; 2021 May; 26(10):. PubMed ID: 34065854
[TBL] [Abstract][Full Text] [Related]
5. Measuring Protein-Protein Interactions in Cells using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET) Assay.
Szewczyk MM; Owens DDG; Barsyte-Lovejoy D
Methods Mol Biol; 2023; 2706():137-148. PubMed ID: 37558946
[TBL] [Abstract][Full Text] [Related]
6. BRET: NanoLuc-Based Bioluminescence Resonance Energy Transfer Platform to Monitor Protein-Protein Interactions in Live Cells.
Mo XL; Fu H
Methods Mol Biol; 2016; 1439():263-71. PubMed ID: 27317001
[TBL] [Abstract][Full Text] [Related]
7. A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopamine.
Kozielewicz P; Bowin CF; Turku A; Schulte G
Mol Pharmacol; 2020 Jan; 97(1):23-34. PubMed ID: 31707356
[TBL] [Abstract][Full Text] [Related]
8. Bioluminescence in G Protein-Coupled Receptors Drug Screening Using Nanoluciferase and Halo-Tag Technology.
Schihada H; Nemec K; Lohse MJ; Maiellaro I
Methods Mol Biol; 2021; 2268():137-147. PubMed ID: 34085266
[TBL] [Abstract][Full Text] [Related]
9. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
[TBL] [Abstract][Full Text] [Related]
10. Studying RAS Interactions in Live Cells with BRET.
Columbus J; Turbyville T
Methods Mol Biol; 2024; 2797():253-260. PubMed ID: 38570465
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms.
Jin HY; Tudor Y; Choi K; Shao Z; Sparling BA; McGivern JG; Symons A
SLAS Discov; 2020 Feb; 25(2):215-222. PubMed ID: 31849250
[TBL] [Abstract][Full Text] [Related]
12. The luminescent HiBiT peptide enables selective quantitation of G protein-coupled receptor ligand engagement and internalization in living cells.
Boursier ME; Levin S; Zimmerman K; Machleidt T; Hurst R; Butler BL; Eggers CT; Kirkland TA; Wood KV; Friedman Ohana R
J Biol Chem; 2020 Apr; 295(15):5124-5135. PubMed ID: 32107310
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of homogeneous proximity immunoassays for preclinical bioanalysis.
Eangoor P; Das S; Pucci V
Bioanalysis; 2020 Dec; 12(24):1757-1766. PubMed ID: 33259228
[TBL] [Abstract][Full Text] [Related]
14. Quantitative, Real-Time Measurements of Intracellular Target Engagement Using Energy Transfer.
Robers MB; Vasta JD; Corona CR; Ohana RF; Hurst R; Jhala MA; Comess KM; Wood KV
Methods Mol Biol; 2019; 1888():45-71. PubMed ID: 30519940
[TBL] [Abstract][Full Text] [Related]
15. Screening for Protein-Protein Interaction Inhibitors Using a Bioluminescence Resonance Energy Transfer (BRET)-Based Assay in Yeast.
Corbel C; Sartini S; Levati E; Colas P; Maillet L; Couturier C; Montanini B; Bach S
SLAS Discov; 2017 Jul; 22(6):751-759. PubMed ID: 28346092
[TBL] [Abstract][Full Text] [Related]
16. Advances in luminescence-based technologies for drug discovery.
Baljinnyam B; Ronzetti M; Simeonov A
Expert Opin Drug Discov; 2023 Jan; 18(1):25-35. PubMed ID: 36562206
[TBL] [Abstract][Full Text] [Related]
17. Bioluminescence and chemiluminescence in drug screening.
Roda A; Guardigli M; Pasini P; Mirasoli M
Anal Bioanal Chem; 2003 Nov; 377(5):826-33. PubMed ID: 12879192
[TBL] [Abstract][Full Text] [Related]
18. Bioluminescence Resonance Energy Transfer (BRET)-Based Synthetic Sensor Platform for Drug Discovery.
Woo J; Hong J; Dinesh-Kumar SP
Curr Protoc Protein Sci; 2017 Apr; 88():19.30.1-19.30.12. PubMed ID: 28369669
[TBL] [Abstract][Full Text] [Related]
19. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.
Cochran JN; Diggs PV; Nebane NM; Rasmussen L; White EL; Bostwick R; Maddry JA; Suto MJ; Roberson ED
J Biomol Screen; 2014 Dec; 19(10):1338-49. PubMed ID: 25156556
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
